Cognition Therapeutics Inc. is a biopharmaceutical company specializing in the research and development of innovative therapeutics for neurodegenerative disorders. Their advanced platform technology aims to target the root causes of Alzheimer’s disease and other cognitive impairments. With promising clinical trial results, the company is at the forefront of revolutionizing treatment options for patients suffering from cognitive decline.
Notification